article thumbnail

Generative AI: Revolutionizing Pharmaceutical Industry and Driving Precision Medicine With Innovation, Equity and Ethics

MedCity News

In the realm of pharmaceuticals, where innovation can be the difference between life and death, the emergence of generative AI, has been nothing short of transformative. By harnessing the capabilities of AI, the pharmaceutical industry is unlocking novel possibilities that were once deemed unattainable.

Ethics 103
article thumbnail

Pharma failing the moral ethics of Covid vaccines

World of DTC Marketing

There is no debate that today’s pharmaceutical companies have helped us lead longer and better lives, but they have made their shareholders and CEOs a lot of money in the process. While many may believe they are helping patients, the reality is that CEOs and shareholders are getting wealthy with pharma stocks.

Ethics 222
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Beyond the Pill: Creating Value with Patient-Centric Pharmaceutical Marketing

Pharma Marketing Network

The pharmaceutical industry is facing a number of challenges, including increasing competition, rising costs, and changing regulations. In order to succeed in this challenging environment, pharmaceutical companies need to adopt a patient-centric approach to marketing. One way is to use patient-generated content (PGC).

article thumbnail

From Classroom to Virtual Reality: How Pharmaceutical Rep Training Has Evolved

Contrarian Sales Techniques

When I first started as a pharmaceutical sales rep a decade ago, training was a rigorous but straightforward affair. We were the bridge between the pharmaceutical companies and the healthcare providers, and our credibility depended on our knowledge and communication skills. It was a lot to take in, but I understood its importance.

article thumbnail

Transforming pharmaceutical manufacturing: The AI revolution

European Pharmaceutical Review

Revolutionising quality control In the backdrop of stringent quality standards and regulatory demands inherent to pharmaceutical manufacturing, the addition of AI technologies introduce a paradigm shift. AI and future perspectives: a glimpse into tomorrow Figure 2: adapted from Saha, G.

article thumbnail

Framework to enable re-use of patient clinical data

European Pharmaceutical Review

FACILITATE , (FrAmework for ClInicaL trIal participants’ daTA reutilisation for a fully Transparent and Ethical ecosystem) is a patient-driven legal framework that intends to help return clinical trial data to study participants, ready for re-use in further research or healthcare practice.

article thumbnail

Making ATMPs a reality for rare disease patients

European Pharmaceutical Review

The implementation of the EU’s Health Technology Assessment Regulation (HTAR) 1 will play a key role in shaping the patient access pathway for ATMPs such as cell and gene therapies. Currently, these therapies primarily target rare or ultra-rare diseases with small patient populations, which therefore limits clinical study sizes.